Q/C TECHNOLOGIES, INC. — Director's Dealing 2014

Aug 25, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Akers Biosciences Inc (AKER)
CIK: 0001321834
Period of Report: 2014-08-22

Reporting Person: RAUCH GARY M (VP of Finance, Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-22	Common Stock	P	1020	$3.15	Acquired	1500	Direct

Footnotes

F1: Does not include the 15,000 stock options previously reported on Form 4 filed with the Securities and Exchange Commission on 6/12/14